| CASE | TOTAL | Q1 | Q2 | Q3 | P for trend | P for interaction |
---|---|---|---|---|---|---|---|
AGE, year | |||||||
 ≥ 75 | 54 | 320 | ref | 0.799 (0.314–2.031) | 2.961 (1.224–7.166) | 0.016 | 0.028 |
  < 75 | 48 | 319 | ref | 1.040 (0.329–3.290) | 1.499 (0.507–4.425) | 0.695 | |
Sex | |||||||
 Male | 78 | 448 | ref | 0.996 (0.430–2.306) | 2.671 (1.216–5.869) | 0.016 | 0.194 |
 Female | 24 | 191 | ref | 0.721 (0.531–0.979) | 1.406 (1.035–1.910) | 0.005 | |
ACS | |||||||
 Yes | 30 | 236 | ref | 1.091 (0.249–4.782) | 1.939 (0.413–9.097) | 0.647 | 0.477 |
 No | 72 | 403 | ref | 0.962 (0.398–2.325) | 2.549 (1.123–5.787) | 0.030 | |
eGFR, mL/min/1.73m2 | |||||||
 ≥ 30 | 81 | 506 | ref | 0.959 (0.419–2.195) | 2.507 (1.133–5.547) | 0.030 | 0.023 |
 < 30 | 31 | 133 | ref | 0.789 (0.129–4.724) | 1.103 (0.152–8.004) | 0.934 | |
Dialysis | |||||||
 Yes | 48 | 149 | ref | 0.594 (0.143–2.467) | 1.015 (0.407–2.529) | 0.761 | 0.320 |
 No | 54 | 490 | ref | 0.857 (0.128–3.374) | 2.575 (1.078–6.152) | 0.043 |